The Laboratory tubes

Product

Excellent quality Sevoflurane - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

To be able to give you benefit and enlarge our business, we also have inspectors in QC Team and assure you our greatest service and products for 820959-17-9, Cysteamine HCL 156-57-0, 1950/7/7, We hope we can have a friendly relationship with businessman from all over the world.
Excellent quality Sevoflurane - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 5kg/month
Order(MOQ): 10g
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial
Package size: 10g/drum
Safety information:  UN 2811 6.1/ PG 1

Mitomycin C

Description

Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.

It is given intravenously to treat upper gastro-intestinal cancers (e.g. esophageal carcinoma), anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours.

Mitomycin C is used in cancers, particularly bladder cancers and intraperitoneal tumours.

Mitomycin C is used in eye surgery where mitomycin C 0.02% is applied topically to prevent scarring during glaucoma filtering surgery and to prevent haze after PRK or LASIK; mitomycin C has also been shown to reduce fibrosis in strabismus surgery.

Mitomycin C is used in esophageal and tracheal stenosis where application of mitomycin C onto the mucosa immediately following dilatation will decrease re-stenosis by decreasing the production of fibroblasts and scar tissue.

Specification (USP/EP)

Item

Specification

Appearance

Blue-violet, crystalline powder

Identification

IR: The IR spectrum of the sample corresponds to the spectrum of reference standard
  HPLC: The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the Assay
pH

6.0~7.5

Water

Not more than 2.5%

Crystallinity

Should conforms

Related Substances
Albomitomycin C

(EP Impurity D)

Not more than 0.5%

Mitomycin B

(EP Impurity C)

Not more than 0.5%

Cinnamamide

(EP Impurity A)

Not more than 0.5%

Mitomycin A

(EP Impurity B)

Not more than 0.5%

Any Individual Unspecified Impurity

Not more than 0.5%

Total Impurities

Not more than 2.0%

Residual Solvents
Methanol

Not more than 3000 ppm

Methylene Chloride

Not more than 600 ppm

Ethyl Acetate

Not more than 5000 ppm

Bacterial Endotoxins

Not more than 10 EU/mg

Assay

Not less than 970 mg/g of Mitomycin


Product detail pictures:

Excellent quality Sevoflurane - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore detail pictures


Related Product Guide:

Sticking to your belief of "Creating solutions of high quality and generating buddies with people from all around the world", we always put the fascination of customers to start with for Excellent quality Sevoflurane - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore , The product will supply to all over the world, such as: Macedonia, Albania, Algeria, So far our products have been exported to east Europe, the Middle East, Southeast, Africa and South America etc. We have 13years professional sales and purchase in Isuzu parts at home and abroad and the ownership of the modernized electronic Isuzu parts checking systems. We honor our core principal of Honesty in business, priority in service and will do our best to offer our customers with high quality products and excellent service.
  • A nice supplier in this industry, after a detail and careful discussion, we reached a consensus agreement. Hope that we cooperate smoothly.
    5 Stars By Lauren from French - 2018.05.22 12:13
    This supplier's raw material quality is stable and reliable, has always been in accordance with the requirements of our company to provide the goods that quality meet our requirements.
    5 Stars By Julie from Swiss - 2018.09.29 13:24